---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-045855"
form_type: "8-K"
ticker: "IMCR"
cik: "0001671927"
company_name: "Immunocore Holdings plc"
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:52:00.786605+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Immunocore prepays $52M Pharmakon loan, terminating agreement 4 years early

## Summary
- Immunocore prepaid $52M ($50M principal, $0.5M interest, $1.5M prepayment premium) on Nov 8, 2024.
- Full repayment terminates all obligations under Pharmakon Loan Agreement originally due Nov 8, 2028.
- Loan was from BioPharma Credit entities; collateral agent BioPharma Credit PLC.
- Subsidiary Immunocore Limited was borrower; parent Immunocore Holdings as credit party.

## SEC filing metadata
- accession: 0001140361-24-045855
- form_type: 8-K
- ticker: IMCR
- cik: 0001671927
- company_name: Immunocore Holdings plc
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671927/000114036124045855/0001140361-24-045855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671927/000114036124045855/ef20038285_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-045855
- JSON: https://secwatch.observer/filing/0001140361-24-045855.json
- Plain text: https://secwatch.observer/filing/0001140361-24-045855.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.